Sublingual Versus Vaginal Misoprostol In Medical Treatment of Second Trimestric Missed Miscarriage (NCT05088707) | Clinical Trial Compass
UnknownNot Applicable
Sublingual Versus Vaginal Misoprostol In Medical Treatment of Second Trimestric Missed Miscarriage
Egypt200 participantsStarted 2021-11-01
Plain-language summary
The aim of this work is to compare the effectiveness of vaginal versus sub-lingual misoprostol for medical treatment of the second trimester missed miscarriage
Who can participate
Age range18 Years – 40 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* All women above 18 years of age
* between 13-26 weeks of gestation.
* Pregnancy is confirmed by a pregnancy test or ultrasound scan.
* missed abortion
* Normal general and gynecological examination.
Exclusion Criteria:
* Hemodynamically unstable.
* Suspected sepsis with temperature 38 °C.
* Concurrent medical illness e.g. hematological, cardiovascular, thromboembolism,
* respiratory illnesses, recent liver disease, or pruritus of pregnancy.
* Presence of intrauterine contraceptive device (IUCD).
* Suspect or proven ectopic pregnancy.
* -Failed medical or surgical evacuation before the presentation.
* Known allergy to misoprostol.